417 Adherence to topical therapy for atopic dermatitis: Barriers and facilitators

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Topical tacrolimus: a new therapy for atopic dermatitis.

Atopic dermatitis is a common problem affecting up to 10 percent of all children. The mainstays of therapy have been oral antihistamines, topical emollients, topical doxepin, and topical corticosteroids. Side effects associated with higher potency topical corticosteroids have limited their use in children and for facial areas. Tacrolimus (Protopic) is an immunosuppressive agent typically used s...

متن کامل

Topical steroid therapy in atopic dermatitis in theory and practice

INTRODUCTION Topical glucocorticosteroids (GCSs) are commonly used in treatment of atopic dermatitis (AD). AIM To assess the patients' compliance with the recommended instructions of the therapy. MATERIAL AND METHODS The study involved 141 adult AD patients. The clinical course of AD and its treatment with GCSs during the last year were analysed. RESULTS In the periods of exacerbation the...

متن کامل

A review of patient adherence to topical therapies for treatment of atopic dermatitis.

Atopic dermatitis (AD) is one of the most commonly diagnosed dermatologic conditions in the United States. Topical agents are the mainstay of treatment for AD, and when used correctly, these therapies generally are straightforward and efficacious. However, poor adherence to treatment can prevent patients from achieving disease control. This article provides a review of the literature on patient...

متن کامل

Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis.

BACKGROUND Adherence in the treatment of chronic inflammatory skin diseases such as atopic dermatitis is poor. Methods to improve adherence have proven difficult. PURPOSE To determine whether a short course of treatment with a high-potency corticosteroid will improve adherence compared to longer treatment studies and if improvement in disease and itch continues after treatment. METHODS 10 p...

متن کامل

BARRIERS AND FACILITATORS TO ASTHMA MEDICATION ADHERENCE 1 Patients

51 Background. Although asthma morbidity can be prevented through long-term controller 52 medication, most patients with persistent asthma do not take their daily inhaled corticosteroid. 53 The objective of this study was to gather patients’ insights into barriers and facilitators to taking 54 long-term daily inhaled corticosteroids as basis for future knowledge translation interventions. 55 Me...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Investigative Dermatology

سال: 2020

ISSN: 0022-202X

DOI: 10.1016/j.jid.2020.03.425